Platinum Sponsor
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients – it drives everything we do.
Silver Sponsor
Gilead’s mission is to advance patient care by developing therapeutics to treat life threatening diseases. We apply biopharmaceutical science to create medicines to treat conditions in the areas of Haematology/Oncology (ZYDELIG® [idelalisib]), HIV, chronic hepatitis B, chronic hepatitis C and systemic fungal infections (AmBisome® [liposomal amphotericin B]).
Silver Sponsor
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Learn more at www.janssen.com.au
Silver Sponsor
Ipsen provides specialty medicines to Healthcare Professionals and their patients suffering from debilitating diseases.
At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals.
Ipsen is the Australian affiliate of a global R & D focused pharmaceutical company.
Bronze Sponsor
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. As an independent company, we plan in generations and focus on long-term success. Our goal is to improve the health and quality of life of patients and our focus is on diseases for which no satisfactory treatment option exists.
As a research-driven company, we actively collaborate with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.